HIP1R and pancreatic adenocarcinoma: We further demonstrated that HIP1R was negatively regulated by miR‐92a‐3p, which modulates the malignant phenotype of PAAD cells in vitro and the tumorigenesis in vivo by targeting PI3K/AKT pathway.